SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-001835
Filing Date
2020-02-28
Accepted
2020-02-28 10:35:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33592
2 filename2.txt TEXT-EXTRACT 2794
  Complete submission text file 0000000000-20-001835.txt   49725
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filed for) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)